Sbi Securities Co., Ltd. Chemomab Therapeutics Ltd. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Chemomab Therapeutics Ltd. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 111 shares of CMMB stock, worth $102. This represents 0.0% of its overall portfolio holdings.
Number of Shares
111
Previous 104
6.73%
Holding current value
$102
Previous $113,000
14.16%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CMMB
# of Institutions
14Shares Held
4.22MCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY1.61MShares$1.49 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA941KShares$865,7100.04% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3738KShares$679,0040.24% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3578KShares$532,0270.12% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$196,0070.08% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $10.5M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...